Is there a difference between synchronous multiple primary cancer and metastasis cancer?

The purpose of this study was to evaluate synchronous multiple primary neoplasms of gynecologic origin in terms of clinical features, diagnosis, treatment, and relapse. Seven patients treated from 2012 to 2017 were studied; five of whom had synchronous multiple primary neoplasms associated with endometrial cancer. Two patients recurred and additional chemotherapy was performed. Synchronous multiple primary neoplasms have a better prognosis than single metastatic tumors, but they should be followed up carefully, as they tend to recur in the latter half of treatment. The authors herein report these seven cases along with a brief review of the literature.

Synchronous multiple primary neoplasms; Endometrial neoplasm; Ovarian neoplasm; Uterine cervical neoplasm

[1] Zaino R., Whitney C., Brady M.F., DeGeest K., Burger R.A., Buller R.E.: “Simultaneously detected endometrial and ovarian carcinomas—a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study”. Gynecol. Oncol., 2001, 83, 355.

[2] Woodruff J.D., Solomon D., Sullivant H.: “Multifocal disease in the upper genital canal”. Obstet. Gynecol., 1985, 65, 695.

[3] Eisner R.F., Nieberg R.K., Berek J.S.: “Synchronous primary neoplasms of the female reproductive tract”. Gynecol. Oncol., 1989, 33, 335.

[4] Matlock D.L., Salem F.A., Charles E.H., Savage E.W.: “Synchronous multiple primary neoplasms of the upper female genital tract”. Gynecol. Oncol., 1982, 13, 271.

[5] Ayhan A., Yalcin O.T., Tuncer Z.S., Gurgan T., Kucukali T.: “Synchronous primary malignancies of the female genital tract”. Eur. J. Obstet. Gynecol. Reprod. Biol., 1992, 45, 63.

[6] Gemer O., Bergman M., Segal S.: “Ovarian metastasis in women with clinical stage I endometrial carcinoma”. Acta Obstet. Gynecol. Scand., 2004, 83, 208.

[7] Siegel R.L., Miller K.D., Jemal A.: “Cancer statistics, 2015”. CA Cancer J. Clin., 2015, 65, 5.

[8] Creasman W.T., Odicino F., Maisonneuve P., Quinn M.A., Beller U., Benedet J.L., et al.: “Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer”. Int. J. Gynaecol. Obstet., 2006, 95, S105.

[9] Shenson D.L., Gallion H.H., Powell D.E., Pieretti M.: “Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium”. Cancer, 1995, 76, 650.

[10] Emmert-Buck M.R., Chuaqui R., Zhuang Z., Nogales F., Liotta L.A., Merino M.J.: “Molecular analysis of synchronous uterine and ovarian endometrioid tumors”. Int. J. Gynecol. Pathol., 1997, 16, 143.

[11] Fujita M., Enomoto T., Wada H., Inoue M., Okudaira Y., Shroyer K.R.: “Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer”. Am. J. Clin. Pathol., 1996, 105, 350.